The Texas federal judge who vacated the Affordable Care Act last year tossed an Obama-era regulation banning federally funded health insurance plans from discriminating on the basis of gender identity, saying the rule violated the Administrative Procedure Act and the Religious Freedom Restoration Act.
A California appeals court has revived a suit accusing an outpatient surgery center of injuring a sedated patient during a medical procedure, saying a legal doctrine that allows juries to presume negligence applied to her case.
A Kentucky federal judge on Wednesday approved a $5 million settlement to resolve a suit accusing a federally-funded health clinic of causing a baby's birth injuries after a doctor allegedly failed to respond to signs of fetal distress.
The Federal Trade Commission’s in-house judge has found dental suppliers Benco Dental and Patterson violated antitrust law by conspiring not to offer discounts to buying groups, but the judge dismissed the agency’s claims against a third company targeted by the enforcement action.
A New York appeals court on Wednesday ordered a new trial in a suit accusing a doctor of botching a patient’s hernia repair surgery, saying the doctor was improperly allowed to testify regarding his “habit,” or usual practice when performing that particular procedure.
A tobacco researcher told lawmakers on Wednesday a proposed bill that would raise the minimum age for buying tobacco products to 21 and would ban flavored e-cigarette products could spawn a public health disaster by creating a black market.
A psychiatric patient's shut-in tendencies and his repeated threats to harm unspecified neighbors could have been enough for the University of Pittsburgh Medical Center to warn residents of his apartment building before he stabbed one of them to death, an attorney and several Justices of the Supreme Court of Pennsylvania suggested Wednesday.
The number of suspected vaping-related illnesses in Massachusetts has risen to 92, with a majority of the 29 cases deemed serious enough to report to federal health officials involving patients who vaped THC products, the state’s health department said Wednesday.
Major drug manufacturers and distributors — including Johnson & Johnson and McKesson — are proposing deals that could be worth a combined $50 billion to resolve large portions of nationwide litigation over pharmaceutical industry liability for the opioid crisis, a source with direct knowledge of the offers told Law360 on Wednesday.
Imprisoned former pharma exec Martin Shkreli has filed his appeal of last resort, asking the U.S. Supreme Court to undo his securities fraud conviction over a jury instruction he says the Second Circuit got wrong.
A Florida magistrate judge on Wednesday recommended the court reject First Choice Healthcare Solutions' attempt to dodge an investor's suit over its former CEO's alleged pump-and-dump scheme, finding the plaintiff convincingly showed that the company could be held liable for its executive's actions.
Philips North America is trying to "bury" a history of litigation over its fitness tracker patents by saying it doesn't know which claims Garmin thinks are invalid and why, Garmin has told a California federal court.
A federal judge has expressed skepticism about part of the theory used to convict five former Insys Therapeutics Inc. executives of bribing doctors to prescribe opioids, wondering whether an indifference to who received the powerful painkiller equated to conspiring with doctors to deal drugs to patients who didn’t need them.
Australian medicinal cannabis company Cronos Australia is planning an AU$20 million ($13.5 million) initial public offering guided by Thomson Geer, one of the company’s backers said Wednesday.
The Florida Supreme Court said Wednesday that it will hear the state's appeal of lower court decisions finding that the regulatory structure in place for licensing medical marijuana treatment centers is unconstitutional.
Quinn Emanuel Urquhart & Sullivan's Meghan McCaffrey helped handle several major cases on behalf of pharmacy benefit management giant Express Scripts, including a $120 million case in which she identified missing discovery documents that resulted in case-terminating sanctions, earning her a spot among the health care law practitioners under 40 honored by Law360 as Rising Stars.
A high-profile antitrust suit alleging Sutter Health gouged union health plans with inflated hospital costs took an unexpected turn Wednesday when a California judge dismissed jurors on the eve of trial, announcing that Sutter had reached a deal in principle with the state attorney general and other plaintiffs.
European private equity shop Permira, guided by Fried Frank, said Wednesday it has clinched its seventh flagship buyout fund after receiving €11 billion ($12.1 billion) from limited partners, with plans to target investments in sectors like technology, consumer products, financial services and health care.
An Alabama state jury has awarded $9 million in a wrongful death suit accusing an urgent care facility and two doctors of providing negligent care to a patient who later died of a blood clot, according to attorneys for the patient's estate.
A Pennsylvania jury on Friday found that a primary care doctor negligently failed to diagnose a bacterial infection in her patient's spine, leading to the man's death from spinal meningitis less than two weeks later, and awarded the man's widow and estate $4.7 million.
California added teeth to its union-friendly cannabis laws with a new requirement that companies sign a so-called "labor peace" agreement with a union within 60 days of their 20th hire or risk losing their marijuana business license.
A judge who wasn’t present for voir dire in a medical malpractice case may have missed important cues about a potential juror’s biases and believability — and may never have a second chance at a first impression — several justices of the Pennsylvania Supreme Court said Tuesday.
A Delaware bankruptcy judge on Tuesday gave his nod for medical diagnostics firm True Health Group LLC's interim disclosure so it can begin soliciting votes late this week on its Chapter 11 plan, despite objections from the federal government that the process is moving too fast.
Investors who sued AmerisourceBergen Corp. for records on the company's compliance with opioid drug distribution controls told a Delaware vice chancellor Tuesday during a one-day trial that the company had mischaracterized their demand to justify denial of documents.
GL Homes has reportedly paid $34 million for 28 acres in Florida, First Industrial Realty Trust is said to have picked up 19.4 acres in Florida, and Healthcare Realty Trust has likely paid more than $60 million for a property in Southern California.
Given the extraordinary risks and evolving regulatory landscape in the rapidly expanding cannabis industry, investors should consider due diligence matters across a wide swath of legal fields when evaluating cannabis-focused transactions, say attorneys with Epstein Becker.
Two recent executive orders on the use of guidance documents by federal agencies represent a major change for virtually every executive agency and a historic assertion of the president’s authority under Article II to oversee the independent regulatory agencies, says Paul Noe, former counselor to the administrator of the White House Office of Information and Regulatory Affairs.
In this short video, Ben Haas and Elizabeth Richards of Latham discuss the U.S. Food and Drug Administration's recent efforts to account for artificial intelligence and real-world evidence in its medical device approval process.
A recently proposed update to Stark Law regulations by the Centers for Medicare & Medicaid Services removes barriers to value-based health care arrangements, and provides other clarifications that will have a larger immediate effect on providers, say Jill Wright and Judith Waltz of Foley & Lardner.
Vince Sliwoski and Molly Nelson of Harris Bricken review all of the presidential candidates' stances on marijuana and rank them based on their current positions as well as their legislative history and prior rhetoric.
As shown by recent case law, including a New Jersey federal court holding last month in Valsartan Products Liability Litigation, there is no "shifting tide" in favor of disclosing litigation funding arrangements, say Matthew Harrison and Stephanie Southwick of Bentham IMF.
While artificial intelligence has already revolutionized the e-discovery field, the development of emotionally intelligent AI promises to explore data in an even more nuanced and human way, thereby further reducing the burden on legal teams, say Lisa Prowse and Brian Schrader at e-discovery services provider BIA.
Although most lawyers are well-prepared to defend or justify the value of an insurance claim for clients, often law firms have not clearly identified their own potential liabilities, planned for adequate insurance or established prudent internal risk management practices, says Victor Sordillo at Sompo International.
With lateral transfers between law firms on the rise, it is more important than ever for partners to understand the steps they must take to adhere to ethics rules and other requirements when making a transition, say attorneys at Harris Wiltshire.
Two likely consequences of a recent U.S Department of Homeland Security rule that redefines “public charge” and elements of a presidential proclamation requiring many immigrants to show they have health insurance have received little attention but may have a significant effect on visa processing, says Jeffrey Gorsky of Berry Appleman.
In the past, when a whistleblower brought a complaint to the government, it was considered significant if the U.S. Department of Justice declined to intervene. In this short video, David Tolley and BJ Trach of Latham discuss how things have changed in recent years.
The New Jersey Supreme Court’s upcoming decision in Wild v. Carriage Funeral Holdings will implicate and affect not only the state’s authorizing statute for medical cannabis, but also its anti-discrimination law and a new statute that expanded protections for workers who use medical marijuana, says Ruth Rauls of Saul Ewing.
The attempt to disqualify Ohio federal judge Dan Aaron Polster from the multidistrict opioid litigation illustrates the complicated nature of disqualification decisions, and the conflict between two theories of judging — the disengaged balls-and-strikes umpire and the engaged, problem-solving citizen-judge, says former Illinois judge Raymond McKoski.
The Seventh Circuit's decision in Lavallee v. Med-1 doesn't mean that debt validation notices can’t be sent through email, and it’s unlikely to affect the Consumer Financial Protection Bureau’s proposed debt collection rule, but it does make clear that collectors must be careful when using electronic communications, say John Redding and Marshall Bell at Buckley.
The Federal Trade Commission's Oct. 2 settlement of pyramid scheme claims with AdvoCare will have far-reaching effects, both for those in the direct selling industry and for those following the ongoing debate over the agency's authority to prosecute FTC violations, say attorneys at Kelley Drye.